UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 405

Sortiert nach

Müllerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications

Endocrine reviews, 2001-10, Vol.22 (5), p.657-674

2001

Volltextzugriff (PDF)

Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia

Clinical genetics, 2015-04, Vol.87 (4), p.362-367

2015

Volltextzugriff (PDF)

Congenital Diaphragmatic Hernia and Chromosome 15q26: Determination of a Candidate Region by Use of Fluorescent In Situ Hybridization and Array-Based Comparative Genomic Hybridization

American journal of human genetics, 2005-05, Vol.76 (5), p.877-882

2005

Volltextzugriff (PDF)

Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): A possible locus for Fryns syndrome

American journal of medical genetics. Part A, 2006-01, Vol.140A (1), p.17-23

2006

Volltextzugriff (PDF)

The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse

Genes & development, 1998-03, Vol.12 (6), p.844-857

1998

Volltextzugriff (PDF)

Mullerian Inhibiting Substance Suppresses Tumor Growth in the C3(1)T Antigen Transgenic Mouse Mammary Carcinoma Model

Proceedings of the National Academy of Sciences - PNAS, 2005-03, Vol.102 (9), p.3219-3224

2005

Volltextzugriff (PDF)

Mullerian inhibiting substance in humans : normal levels from infancy to adulthood

The journal of clinical endocrinology and metabolism, 1996-02, Vol.81 (2), p.571-576

1996

Volltextzugriff (PDF)

Specific Interaction of Type I Receptors of the TGF-β Family with the Immunophilin FKBP-12

Science (American Association for the Advancement of Science), 1994-07, Vol.265 (5172), p.674-676

1994

Volltextzugriff (PDF)

Molecular Basis of Mammalian Sexual Determination: Activation of Müllerian Inhibiting Substance Gene Expression by SRY

Science (American Association for the Advancement of Science), 1994-12, Vol.266 (5190), p.1494-1500

1994

Volltextzugriff (PDF)

Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer

Current molecular medicine, 2016-03, Vol.16 (3), p.222

2016

Volltextzugriff (PDF)

Measurements of Serum Müllerian Inhibiting Substance in the Evaluation of Children with Nonpalpable Gonads

The New England journal of medicine, 1997-05, Vol.336 (21), p.1480-1486

1997

Volltextzugriff (PDF)

Activin Receptor-Like Kinase 1 Modulates Transforming Growth factor-β 1 Signaling in the Regulation of Angiogenesis

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (6), p.2626-2631

2000

Volltextzugriff (PDF)

Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level

Endocrinology (Philadelphia), 1999-10, Vol.140 (10), p.4732-4738

1999

Volltextzugriff (PDF)

New insights into mullerian inhibiting substance and its mechanism of action

Journal of endocrinology, 1998-07, Vol.158 (1), p.1-6

1998

Volltextzugriff (PDF)

SURGICAL TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

Endocrinology and metabolism clinics of North America, 2001-03, Vol.30 (1), p.137-154

2001

Volltextzugriff (PDF)

SRY Recognizes Conserved DNA Sites in Sex-Specific Promoters

Proceedings of the National Academy of Sciences - PNAS, 1993-02, Vol.90 (3), p.1097-1101

1993

Volltextzugriff (PDF)

Requirement for phosphatidylinositol-3'-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse

Endocrinology (Philadelphia), 1999-02, Vol.140 (2), p.941-949

1999

Volltextzugriff (PDF)

Diagnostic Utility of Müllerian Inhibiting Substance Determination in Patients with Primary and Recurrent Granulosa Cell Tumors

Gynecologic oncology, 1999-04, Vol.73 (1), p.51-55

1999

Volltextzugriff (PDF)

Nitrofen induces a redox-dependent apoptosis associated with increased p38 activity in P19 teratocarcinoma cells

Toxicology in vitro, 2005-02, Vol.19 (1), p.1-10

2005

Volltextzugriff (PDF)

Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment

The Journal of biological chemistry, 1988-12, Vol.263 (35), p.18961-18964

1988

Volltextzugriff (PDF)

Mullerian Inhibiting Substance: A Gonadal Hormone with Multiple Functions

Endocrine reviews, 1993-04, Vol.14 (2), p.152-164, Article 152

1993

Volltextzugriff (PDF)

Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression

Molecular endocrinology (Baltimore, Md.), 2001-06, Vol.15 (6), p.946-959

2001

Volltextzugriff (PDF)

Mullerian Inhibiting Substance Inhibits Cervical Cancer Cell Growth via a Pathway Involving p130 and p107

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (26), p.15601-15606

2003

Volltextzugriff (PDF)

A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligands

The Journal of biological chemistry, 1994-05, Vol.269 (21), p.14861-14864

1994

Volltextzugriff (PDF)

Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and sertoli cells coincides with their mitotic activity

Endocrinology (Philadelphia), 1992-08, Vol.131 (2), p.854-862

1992

Volltextzugriff (PDF)

1 – 25 von 405

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(385)
Mit Volltextzugriff
(352)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(403)
Japanisch
(71)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(271)
Life Sciences & Biomedicine
(243)
Animals
(191)
Female
(177)
Humans
(173)
Male
(150)
Biological And Medical Sciences
(148)
Anti-Mullerian Hormone
(117)
Glycoproteins
(104)
Rats
(83)
Medical Sciences
(79)
Fundamental And Applied Biological Sciences. Psychology
(70)
Surgery
(65)
Pediatrics
(56)
Mice
(52)
Endocrinology & Metabolism
(51)
Growth Inhibitors
(41)
Infant, Newborn
(40)
Testicular Hormones - Pharmacology
(37)
Infant
(34)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Müllerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications

Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia

Congenital Diaphragmatic Hernia and Chromosome 15q26: Determination of a Candidate Region by Use of Fluorescent In Situ Hybridization and Array-Based Comparative Genomic Hybridization

Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): A possible locus for Fryns syndrome

The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse

Mullerian Inhibiting Substance Suppresses Tumor Growth in the C3(1)T Antigen Transgenic Mouse Mammary Carcinoma Model

Mullerian inhibiting substance in humans : normal levels from infancy to adulthood

Specific Interaction of Type I Receptors of the TGF-β Family with the Immunophilin FKBP-12

Molecular Basis of Mammalian Sexual Determination: Activation of Müllerian Inhibiting Substance Gene Expression by SRY

Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer

Measurements of Serum Müllerian Inhibiting Substance in the Evaluation of Children with Nonpalpable Gonads

Activin Receptor-Like Kinase 1 Modulates Transforming Growth factor-β 1 Signaling in the Regulation of Angiogenesis

Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level

New insights into mullerian inhibiting substance and its mechanism of action

SURGICAL TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

SRY Recognizes Conserved DNA Sites in Sex-Specific Promoters

Requirement for phosphatidylinositol-3'-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse

Diagnostic Utility of Müllerian Inhibiting Substance Determination in Patients with Primary and Recurrent Granulosa Cell Tumors

Nitrofen induces a redox-dependent apoptosis associated with increased p38 activity in P19 teratocarcinoma cells

Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment

Mullerian Inhibiting Substance: A Gonadal Hormone with Multiple Functions

Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression

Mullerian Inhibiting Substance Inhibits Cervical Cancer Cell Growth via a Pathway Involving p130 and p107

A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligands

Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and sertoli cells coincides with their mitotic activity

Suchergebnisse filtern